ATTN: We are committed to keeping our patients informed regarding the recent cybersecurity incident involving McKesson. At this time, we are continuing to monitor the situation closely and are working to obtain the most current information available. We will provide updates as we receive additional information from McKesson and learn more about any potential impact. Thank you for your patience and trust as we navigate this situation together. CLICK HERE for more information.

Clinical Research & Trials

USO 24042

A Long-Term Follow-up Study for Subjects Previously Treated with A Century Therapeutics Cellular Therapy Product (CNTY-LTFU-01)

 

Disease Types: Cellular & Gene

Eligibility Requirements:

1. Subject has provided written informed consent prior to any LTFU study-specific procedures

2. Subject received at least one treatment with a cellular therapy product in an eligible index trial

3. Subject was withdrawn, early discontinued or completed an eligible index trial

4. Subject is willing and able to comply with scheduled visits, study plan, and other study procedures

For more information on this trial CLICK HERE .

Available at: